This combination contains Cefuroxime Axetil 125 mg, a second-generation cephalosporin antibiotic, and Potassium Clavulanate 31.25 mg, a beta-lactamase inhibitor.
Cefuroxime Axetil: Works by inhibiting bacterial cell wall synthesis, killing the infection-causing bacteria.
Potassium Clavulanate: Prevents resistant bacteria from inactivating Cefuroxime, thereby enhancing its antibacterial activity.
Available in oral suspension/dry syrup form for pediatric use.
It is commonly prescribed for treating bacterial infections such as: